CytoDyn Inc.
CYDY · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | -$0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | 0.3% | – | – | 80.1% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | -145.7% | – | – | -73,298.1% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | -63.3% | – | – | -79,255.6% |
| EPS Diluted | 0.002 | -0.053 | -0.095 | -0.43 |
| % Growth | 103.4% | 44.5% | 77.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |